Fujikawa Takahiko, Hirata Tetsuya, Hosoo Shingo, Nakajima Kenji, Wada Atsunori, Yurugi Yutaka, Soya Hideaki, Matsui Takashi, Yamaguchi Akihiko, Ogata Masato, Nishibe Sansei
Laboratory of Molecular Prophylaxis and Pharmacology, Department of Pharmaceutical Sciences , Suzuka University of Medical Science , 3500-3 Minamitamagaki-cho, Suzuka, Mie 513-8670 , Japan ; Department of Biochemistry and Proteomics , Mie University Graduate School of Medicine , 2-174 Edobashi, Tsu, Mie 514-8507 , Japan.
R&D Center , Kobayashi Pharmaceutical Co. Ltd , 1-30-3 Toyokawa, Ibaraki, Osaka 567-0057 , Japan.
J Nutr Sci. 2012 Sep 5;1:e10. doi: 10.1017/jns.2012.12. eCollection 2012.
Eucommia leaves (Eucommia ulmoides Oliver) contain chlorogenic acid (a caffeic acid derivative) and geniposidic acid and asperuloside (ASP), iridoid glucosides used in beverages. We used a metabolic syndrome rat model, produced by feeding a 35 % high-fat diet (HFD), to examine potential anti-obesity and anti-metabolic syndrome effects and mechanisms of chronic administration of ASP. These effects were compared with Eucommia leaf extract (ELE), the positive control, which exhibits anti-obesity effects. A total of six rats were studied for 3 months in five groups. ASP suppressed body weight, visceral fat weight, food intake and circulating levels of glucose, insulin and lipids, and increased the plasma adiponectin level in rats on a HFD. These effects are similar to those of ELE, except for the influence on the plasma glucose level. RT-PCR studies showed that ASP (like ELE with known anti-obesity effects) diminished isocitrate dehydrogenase 3α, NADH dehydrogenase flavoprotein 1 (Comp I) mRNA and fatty acid synthase levels (white adipose tissue), increased carnitine palmitoyltransferase 1α and acyl-CoA dehydrogenase, very-long-chain mRNA levels (liver), and increased Glut4, citrate synthase, isocitrate dehydrogenase 3α, succinyl CoA synthase, peroxisomal 3-ketoacyl-CoA thiolase, dihydrolipoamide succinyl transferase and succinate dehydrogenase mRNA levels (skeletal muscle) under HFD conditions. Interestingly, ASP administration resulted in significantly increased mRNA levels of uncoupling protein 1 (UCP1) in the brown adipose tissue of HFD-fed rats; ELE did not affect the expression of UCP1. The increased expression of UCP1 may be negated by many ingredients other than ASP in the ELE. These findings suggest that chronic administration of ASP stimulates anti-obesity and anti-metabolic syndrome activity in HFD-fed rats across several organs, similar to ELE administration; thus, ASP may be an important ingredient of ELE.
杜仲叶(杜仲)含有绿原酸(一种咖啡酸衍生物)、京尼平苷酸和梓醇(ASP),后者是用于饮料中的环烯醚萜苷。我们使用通过喂食35%高脂饮食(HFD)建立的代谢综合征大鼠模型,来研究长期给予ASP的潜在抗肥胖和抗代谢综合征作用及机制。将这些作用与具有抗肥胖作用的阳性对照杜仲叶提取物(ELE)进行比较。总共六只大鼠被分为五组,研究3个月。ASP抑制了HFD喂养大鼠的体重、内脏脂肪重量、食物摄入量以及循环中的葡萄糖、胰岛素和脂质水平,并提高了血浆脂联素水平。这些作用与ELE相似,除了对血浆葡萄糖水平的影响。逆转录-聚合酶链反应(RT-PCR)研究表明,ASP(与具有已知抗肥胖作用的ELE一样)降低了异柠檬酸脱氢酶3α、NADH脱氢酶黄素蛋白1(复合体I)的mRNA水平以及脂肪酸合酶水平(白色脂肪组织),提高了肉碱棕榈酰转移酶1α和酰基辅酶A脱氢酶、极长链的mRNA水平(肝脏),并提高了葡萄糖转运蛋白4、柠檬酸合酶、异柠檬酸脱氢酶3α、琥珀酰辅酶A合成酶、过氧化物酶体3-酮酰基辅酶A硫解酶、二氢硫辛酰胺琥珀酰转移酶和琥珀酸脱氢酶的mRNA水平(骨骼肌),这些均处于HFD条件下。有趣的是,给予ASP导致HFD喂养大鼠棕色脂肪组织中解偶联蛋白1(UCP1)的mRNA水平显著升高;ELE未影响UCP1的表达。ELE中除ASP外的许多成分可能抵消了UCP1表达的增加。这些发现表明,长期给予ASP可刺激HFD喂养大鼠多个器官的抗肥胖和抗代谢综合征活性,与给予ELE相似;因此,ASP可能是ELE的一种重要成分。